Astex Pharmaceuticals

Astex Pharmaceuticals (NASDAQ: ASTX) is dedicated to the discovery and development of novel small molecule therapeutics with a focus on oncology.  The Company is developing a proprietary pipeline of novel therapies and is creating de-risked products for partnership with leading pharmaceutical companies. Astex Pharmaceuticals is the result of the merger in 2011 of US-based pharmaceutical company SuperGen (NASDAQ: SUPG) and Astex Therapeutics Limited, a privately held, UK-based biotechnology company.

Astex is headquartered in Dublin, CA, US and has a Research Centre in Cambridge, United Kingdom.